Steve DewhurstStephen Dewhurst, Ph.D., has been named vice dean for research at the University of Rochester School of Medicine and Dentistry. A faculty member since 1990 and past senior associate dean for basic research, Dewhurst will lead the School’s research strategic planning process and help advance its research priorities by identifying areas of excellence in which to make strategic investments; strengthening the research infrastructure; improving education and training; and promoting collaborations and alliances that will result in increased research funding.

The new position was recommended by a faculty-led strategic planning committee headed by Dirk Bohmann, Ph.D., and Lynne E. Maquat, Ph.D. As vice dean for research, Dewhurst will work closely with the senior associate deans for basic and clinical research, J. Edward Puzas, Ph.D., and Thomas A. Pearson, M.D., M.P.H., Ph.D., to accomplish these goals.

“There’s no doubt that this is a challenging time in science: Researchers are faced with an extremely competitive funding environment and a scientific landscape that is changing more rapidly than ever before,” said Mark B. Taubman, M.D., dean of the School of Medicine and Dentistry. “We take these issues very seriously and believe Steve will help leadership and faculty respond to these challenges. With a wide-ranging understanding of research and an outstanding track record of organizing successful institutional collaborations, he is the ideal candidate for the job.”

Full Announcement

TEN announcementEach year, 11 federal agencies set aside more than $2 billion to fund research and development at small businesses, through the Small Business Innovation Research (SBIR) Program and the Small Business Technology Transfer (STTR) Program. Federal agencies issue solicitations to small companies, including start-ups, for proposals on specific research and product development.

Come to this seminar to learn how you can apply for SBIR and STTR grants to fund your research and new product development. Free to qualified small
businesses. 

Register for one or both sessions by Friday, April 26, 2013Call HTR’s Mike Riedlinger at 585.413.9061 or send him an e-mail.

What You Will Learn in SBIR Basics (morning session – 9:00 am to noon)
For any small business engaged in technology research and development

  • Overview of SBIR and STTR programs
  • How entrepreneurs, small businesses and academic researchers can tap into these funds
  • Meet area SBIR & STTR award winners that will share their experiences and proposal tips

What You Will Do in the Grant Writing Workshop (afternoon session 1:00 – 4:00 pm – bring a lap top or iPad)
For small businesses in the optics industry and others seeking and ready to write NSF SBIR grants

  • Search for open NSF grant topics
  • Outline a grant proposal
  • Enroll in the government’s system for grant submissions

Who Should Attend:

  • Entrepreneurs seeking to start a technology business
  • University researchers commercializing their technology
  • Phase I award winners planning a Phase II proposal
  • Past Phase I applicants who have not yet won an award

SBIR proposals are two times more likely to be funded when small businesses partner with a university or research institution. Meet technology commercialization and tech transfer officials from area universities and research institutions that partner with entrepreneurs and small businesses on these proposals.  

 Presenters at this seminar include:

  • NSF Grant Recipient - Victoria Van Voorhis, Second Avenue Software
  • Cindy Gary, University of Rochester
  • Mike Riedlinger, High Tech Rochester
  • Jean Kase, PTAC
  • Jack McGowan, Insyte Consulting
  • Drake Thomas, SBDC

JEAN KASE
The Entrepreneurs Network – TEN

Helping High-Growth Companies Succeed

Email: jeankase@ten-ny.org | Website: http://TEN-NY.org
Monroe County Office:  50 W Main Street, Ste 8100, Rochester, NY  14614 | Telephone:  585.753.2031
HTR Office:  150 Lucius Gordon Drive, Ste 100, W Henrietta, NY  14586 | Telephone:  585.214.2423

RocNext Announcement

Each stage of Scott Catlin’s career has taken him in a slightly different direction, but, as a whole, it amounts to an ideal path leading to his new role as vice president for innovation and technology commercialization at the University of Rochester.

Catlin, who started in the job on March 1, took advantage of an Air Force ROTC program to pay for his college education, but he later recognized how the decision was worth more than cost of tuition.

“Even though I did it originally for financial reasons, I got so much out of it from a leadership and management perspective. If I had known then what I know now, I probably would have done it even if they didn’t pay for school,” said Catlin, who earned a bachelor’s degree in optical engineering at UR in 1992.

Three years later, Catlin graduated from Notre Dame Law School. Afterward he served as a judge advocate general, mainly handling criminal prosecutions before going to work for about a year as a management consultant at Bain Capital.

Full RocNext Article

 

HomeIn today’s world, raising capital for early stage technologies has become a grueling process, not only has government funding been cut, but companies and investors, too, have stopped taking big risks on new projects.  This new way of doing business has forced researchers and Universities around the country to find innovative ways to bring in the capital needed to take their projects to the next level.

The University of Rochester, in an effort to help its researchers hunt down early stage, proof-of-concept, capital, decided to reach out and explore alternative investment avenues. So, when the University was first contacted by Mike Totterman, chairman of Innovocracy, they were thrilled to hear of his new crowdfunding platform focused on promoting and raising funds for early-stage academic research.

Once the platform was completed, two University of Rochester researches decided to give the new funding initiative a try. Dr. Daniel Mruzek, a psychologist and autism expert, and Dr. Stephen McAleavey, a biomedical engineer, had developed a novel toilet-training procedure using an electronic moisture pager and corresponding curriculum for children with autism.

The team had successfully tested the device in children with other developmental disabilities but needed additional funding to test the device in children with autism. Fortunately, Innovocracy provided the team with a unique platform that allowed them to reach out to the community and request support to raise the additional capital needed to complete their project. In less than two weeks the team was able to raise 50% of the funds required for the trial, by the end of month the team had exceeded its funding goal and were able to raise over $9,000 to carry out the additional testing on the device.

Next, a group of University of Rochester undergraduate biomedical engineering students decided to give the platform a try. The team had developed a unique handlebar device, the MonoMano, in their senior design course that allows physically handicapped individuals to effortlessly ride a bicycle. In order to develop and distribute the device on a large scale the team needed to raise additional capital to cover manufacturing costs, so they decided to post their project on the Innovocracy platform in hopes they’d garner enough financial support to continue production.  By the end of the month, the students rose close to $6,000, which they ultimately used to manufacture additional handle bar units that were then sent to SportsNet and the Wounded Warriors Project for distribution.

Right now, two new University of Rochester projects are up on the Innovocracy platform and open for donation. The first technology, entitledMindWriter, is a software module that works in concert with a word-processing program to make the writing process productive and rewarding. The module was developed by Dr. Deborah Rossen, Associate Professor and Director of the College Writing Program, and is currently in its third iteration and is being tested by student writers at the University of Rochester. To help refine the program and begin user testing it at other institutions, Dr. Rossen is looking to raise $5,000, by May 1, 2013.  To learn more about Dr.Rossen’s project and to donate to her program, please visit her Innovocracy page for additional information.

The second technology, entitled “Science Buddies Kits”, is made up of hands-on science activities and kits for elementary school-aged children that can easily be implemented in after-school programs. The kits were developed by Liam Casey, Research Assistant Professor of Environmental Medicine, and aim to employ an innovative and unique combination of characteristics that increase the likelihood of adoption by informal science educators. Liam is looking to raise $5,000, by May 1, 2013, to continue development and distribution of his kits to after school programs. To learn more about Liam’s kits and to donate to his project, please visit his Innovocracy page for additional information.

In just over a year, Innovocracy has been able to launch an incredibly successful crowdfunding initiative that has helped a number of University of Rochester researchers and students bring their technologies to market. Without Innovocracy, and others like it, some academic innovations may never get the chance to reach their true commercial potential.

Innovocracy’s goal is to provide a platform for innovators to solicit funds for academic projects. Contributions to Innovocracy projects are no strings attached donations and over 90% of the funds are distributed directly back to the innovators via their educational institutions. No equity changes hands and if interested, but not required, innovators may provide incentives to supporters (incentives may include updates, sample products and other thank you items).

Innovocracy is currently accepting new project proposals; so, if this is something you’d like to get involved in please Contact Innovocracy directly for more information.  We strongly encourage any and all University of Rochester faculty and students looking to fund small projects, or a piece of a project, to take a quick minute to fill out Innovocracy’s short Questionnaire to find out if your project would be a good fit for the platform. If you have any additional questions please visit Innovocracy’s website, or give Innovocracy a call at 585-419-4955

Innovocracy is an independent organization, which is not owned or controlled by or otherwise affiliated with the University of Rochester.

Drug Discovery 1The Drug Discovery Pilot Award program, jointly funded by the Medical Center and the Moulder Center for Drug Discovery Research at Temple University, is accepting proposal applications until Friday, May 3. The purpose of the program is to support projects in drug development research that result in technology development, extramural funding, and commercialization.

The program will fund early exploratory studies at Rochester with grants ranging between $4,000 and $8,000. The program also provides up to $25,000 to support “lead finding studies.” Contact Michael Rusnak at 276-6610 with any questions regarding submissions.

Ortho AnnouncementThe University of Rochester Medical Center’s Department of Orthopaedics and Rehabilitation has been ranked No. 1 in the nation in National Institutes of Health funding for orthopaedic research, according to data released by the Blue Ridge Institute for Medical Research.

The URMC Center for Musculoskeletal Research (CMSR) received $4.86 million in peer-reviewed NIH research grants in 2012, surpassing institutions such as Washington University, Johns Hopkins and Duke University. At a time when research dollars are becoming increasingly scarce, the CMSR upped its funding by 30 percent over the previous year.

The past four years the CMSR has come in at No. 2 in orthopaedic funding, according to the Blue Ridge Institute. Since 2000 it has consistently ranked among the top five NIH-funded musculoskeletal programs in the country.

Full Announcement

rob clarkA message from University President Joel Seligman

I am delighted today to announce that the Board of Trustees has voted approval of my appointment of Dr. Robert L. Clark as Senior Vice President for Research and his reappointment as Dean of the Hajim School of Engineering and Applied Sciences. Both appointments will begin on April 1, 2013 and continue through June 30, 2018. Rob will devote 50 percent of his time to each position.

Since July of 2012, Rob has served as interim Senior Vice President for Research and as Dean of the Hajim School. His service in both roles has been exemplary. Among other highlights of his work as Senior Vice President, Rob has orchestrated a review of Information Technology, supervised efforts to initiate pilot online programs, led a successful search for a new Associate Vice President for Technology Transfer and worked with the Finger Lakes Regional Economic Development Council in support of the University’s Health Sciences Center for Computational Innovation, which resulted in an additional $5 million of support for our Center.

In February 2013, I also received reviews of Rob’s performance as Dean of the Hajim School from Provost Peter Lennie and a faculty committee within the Hajim School comprising Sandhya Dwarkadas, Eby Friedman, Stephen McAleavey and James Zavislan. Both reviews urged Rob’s reappointment as Dean, citing such achievements as growth in the faculty, introduction of new master’s programs, and a significant increase in undergraduate enrollment in engineering.

Full Announcement

tech transfer banner

Scott Catlin has been appointed associate vice president for innovation and technology commercialization. He will oversee the Office of Technology Transfer at the University of Rochester.

“Scott Catlin’s breadth of knowledge, expertise, and corporate experience will serve us well and advance the mission of the Office of Technology Transfer,” said Robert Clark, interim senior vice president for research.

Catlin is currently legal section head for Abbott Medical Optics Inc. in Santa Ana, Calif., where he managed a team of 18 attorneys and support staff. Catlin earned his B.S. in optical engineering at the University of Rochester in 1992, graduating summa cum laude. Three years later, he graduated cum laude from the University of Notre Dame Law School with his Juris Doctorate. He is registered to practice before the U.S. Patent & Trademark Office and is a member of the Licensing Executives Society and American Intellectual Property Association.

“I look forward to building bridges between the University’s researchers and the commercial world,” said Catlin. “The goal is to turn the University’s cutting-edge innovation into products and services that benefit patients, society and the environment, while also helping to create jobs in the local community.”

 

Full Announcement

The Office of Technology Transfer, in cooperation with the Center for Entrepreneurship proudly present F.I.R.E. in September:

“The Importance of MTAs and CDAs in Shared Research: All You Wanted to Know but Were Afraid to Ask”

Are you confused about Materials Transfer Agreements and Confidentiality Agreements? Would you like to know more about them? This presentation is designed to help maximize your understanding of these Agreements and to learn about the University’s requirements for their implementation. This presentation is open to the research community and to anyone who would like to learn more about when these agreements are needed, the implications of certain language used in the agreement, and how they affect the University’s research.

Where: the Class of ’62 Auditorium (G-9425 & 1-9425)
When: *Tuesday, 11 September 2012, 12:00 – 1:00 PM

*PLEASE NOTE THE TIME AND DAY CHANGE ABOVE

A light lunch will be served following the presentation. Please contact David Englert, or call 585.784.8856 for more information or to register for this event.

Although the F.I.R.E. Series continues to be free and open to the public, a small fee for parking may apply (usually between $5 and $6). Registration would be appreciated by noon Monday, 11 September 2012.

One of the persistent barriers to the commercialization of university-based technologies is the period between when federal research funding runs out and the point at which industry steps in and takes over development. In between these two stages reside a daunting number of scientific and regulatory hurdles that must be overcome before a technology has advanced enough to attract the private sector. This phenomenon is particularly pronounced in the field of medicine where industry has become far more selective and risk-adverse when considering new technologies. As a consequence, many promising ideas remained frozen at an early stage of development in academic labs.

Follow this link for the full article…

Follow

Get every new post delivered to your Inbox.

Join 446 other followers